Skip to main content

Management of Complications: Chemotherapy Related Complications, Acute Bowel Obstruction, Symptomatic Ascites and Pleural Effusion, Pulmonary Embolism, Deep Vein Thrombosis, Severe Pain, Chylous Ascites

  • 178 Accesses

Abstract

Patients with gynaecological cancer experience significant symptom burden throughout their disease course and treatment, which negatively impacts their quality of life. The most common symptoms and non-surgical complications amongst gynaecological oncology patients include pain, haemorrhage, deep vein thrombosis/pulmonary embolism, ascites/pleural effusion, chylous ascites, bowel obstruction and chemotherapy-related side effects. When treating women with gynaecological cancer, goals of care may evolve from cure to symptom control and maintaining quality of life during terminal stages. The management of non-surgical complication in gynaecological oncology is discussed in this chapter.

Keywords

  • Chemotherapy-related side effects
  • Ascites
  • Pleural effusion
  • Venous thromboembolism
  • Pain
  • Acute bowel obstruction
  • Chylous ascites

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-3-030-94110-9_10
  • Chapter length: 16 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   149.00
Price excludes VAT (USA)
  • ISBN: 978-3-030-94110-9
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Hardcover Book
USD   199.99
Price excludes VAT (USA)
Fig. 10.1

References

  1. Rodgers GM 3rd, Becker PS, Blinder M, Cella D, Chanan-Khan A, Cleeland C, et al. Cancer- and chemotherapy- induced anemia. J Natl Compr Cancer Netw. 2012;10:628–53.

    CrossRef  Google Scholar 

  2. Kuter DJ. Managing thrombocytopenia associated with cancer chemotherapy. Oncology (Willis-ton Park). 2015;29:282–94.

    Google Scholar 

  3. de Naurois J, Novitzky-Basso I, Gill JM, Marti F, Cullen MH, Roila F. Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol. 2010;21(supplement 5):v252–6.

    PubMed  CrossRef  Google Scholar 

  4. National Comprehensive Care Network I. NCCN Clinical Practice Guidlines for Oncology (NCCN Guidlines); Antiemesis. 2015.

    Google Scholar 

  5. Andreyev J, Ross P, Donnellan C, Lennan E, Leonard P, Waters C, et al. Guidance on the management of diarrhoea during cancer chemotherapy. Lancet Oncol. 2014;15:e447–60.

    PubMed  CrossRef  Google Scholar 

  6. Brewer JR, Morrison G, Dolan ME, Fleming GF. Chemotherpay-induced peripheral neuropathy. Current status and progress. Gynecol Oncol. 2015;140(1):176–83.

    PubMed  PubMed Central  CrossRef  CAS  Google Scholar 

  7. Curigliano G, Cardinale D, Super T, Plataniotis G, de Azambuja E, Sandri MT, Criscitiello C, et al. On behalf of the ESMO Guidelines Working Group, Cardiovascular toxicity induced by chemo-therapy, targeted agents and radiotherapy: clinical practice guidelines. Ann Oncol. 2012;23(Supplement 7):vii155–66.

    PubMed  CrossRef  Google Scholar 

  8. Ripamonti C. Management of bowel obstruction in advanced cancer. Curr Opin Oncol. 1994;6:351–7.

    CAS  PubMed  CrossRef  Google Scholar 

  9. Ripamonti C, Bruera E. Palliative management of malignant bowel obstruction. Int J Gynecol Cancer. 2002;12:135–43.

    PubMed  CrossRef  Google Scholar 

  10. Dvoretsky PM, Richards KA, Angel C, et al. Distribution of disease at autopsy in 100 women with ovarian cancer. Human Pathol. 1988;19:57–83.

    CAS  CrossRef  Google Scholar 

  11. Kolomainen DF, Riley J, Wood J, Barton DPJ. Surgical management of bowel obstruction in gynaecological cancer. Obstet Gynaecol. 2017;19:63–70.

    CrossRef  Google Scholar 

  12. Feuer DJ, Broadley KE. Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev. 2000;2000(1):CD001219.

    PubMed Central  Google Scholar 

  13. Ten Broek RPG, Krielen P, Di Saverio S, et al. Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2017 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group. World J Emerg Surg. 2018;19(13):24.

    CrossRef  Google Scholar 

  14. Catena F, Ansaloni L, Gazzotti F, et al. Small bowel tumours in emergency surgery: specificity of clinical presentation. ANZ J Surg. 2005;75(11):997–9.

    PubMed  CrossRef  Google Scholar 

  15. Vallicelli C, Coccolini F, Catena F, et al. Small bowel emergency surgery: literature’s review. World J Emerg Surg. 2011;6(1):1.

    PubMed  PubMed Central  CrossRef  Google Scholar 

  16. Yeo HL, Lee SW. Colorectal emergencies: review and controversies in the management of large bowel obstruction. J Gastrointest Surg. 2013;17(11):2007–12.

    PubMed  CrossRef  Google Scholar 

  17. Pisano M, Zorcolo L, Merli C, et al. 2017 WSES guidelines on colon and rectal cancer emergencies: obstruction and perforation. World J Emerg Surg. 2018;13(13):36.

    PubMed  PubMed Central  CrossRef  Google Scholar 

  18. Catena F, Pasqualini E, Tonini V, Avanzolini A, Campione O. Emergency surgery for patients with colorectal cancer over 90 years of age. Hepatogastroenterology. 2002;49(48):1538–9.

    PubMed  Google Scholar 

  19. Takahashi H, Okabayashi K, Tsuruta M, Hasegawa H, Yahagi M, Kitagawa Y. Self-expanding metallic stents versus surgical intervention as palliative therapy for obstructive colorectal cancer: a meta-analysis. World J Surg. 2015;39(8):2037–44.

    PubMed  CrossRef  Google Scholar 

  20. Rath K, Loseth D, Muscarella P, Phillips G, Fowler J, Mall D, et al. Outcomes following percutaneous upper gastrointestinal decompressive tube placement for malignant bowel obstruction in ovarian cancer. Gynecol Oncol. 2013;129:103–6.

    CAS  PubMed  PubMed Central  CrossRef  Google Scholar 

  21. Tamsma J. The pathogenesis of malignant ascites. Cancer Treat Res. 2007;134:109–18.

    CAS  PubMed  Google Scholar 

  22. Meyer L, Suidan R, Sun C, Westin S, Coleman RL, Mills GB. The management of malignant ascites and impact on quality of life outcomes in women with ovarian cancer. Expert Rev Qual Life Cancer Care. 2016;1(3):231–8.

    PubMed  PubMed Central  CrossRef  Google Scholar 

  23. Hodge C, Badgwell BD. Palliation of malignant ascites. J Surg Oncol. 2019;120(1):67–73.

    PubMed  CrossRef  Google Scholar 

  24. Macdonald R, Kirwan J, Roberts S, Gray D, Allsopp L, Green J. Ovarian cancer and ascites: a questionnaire on current management in the United Kingdom. J Palliat Med. 2006;9:1264–70.

    PubMed  CrossRef  Google Scholar 

  25. O’Neill MJ, Weissleder R, Gervais DA, Hahn PF, Mueller PR. Tunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites. AJR Am J Roentgenol. 2001;177:615–8.

    PubMed  CrossRef  Google Scholar 

  26. Pockros PJ, Esrason KT, Nguyen C, Duque J, Woods S. Mobilization of malignant ascites with diuretics is dependent on ascitic fluid characteristics. Gastroenterology. 1992;103:1302–6.

    CAS  PubMed  CrossRef  Google Scholar 

  27. Hirte HW, Miller D, Tonkin K, Findlay B, Capstick V, Murphy J, et al. A randomized trial of paracentesis plus intraperitoneal tumor necrosis factor-α versus paracentesis alone in patients with symptomatic ascites from recurrent ovarian carcinoma. Gynecol Oncol. 1997;64:80–7.

    CAS  PubMed  CrossRef  Google Scholar 

  28. Kipps E, Tan DS, Kaye SB. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nat Rev Cancer. 2013;13:273–82.

    CAS  PubMed  PubMed Central  CrossRef  Google Scholar 

  29. Seimetz D, Lindhofer H, Bokemeyer C. Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM × anti-CD3) as a targeted cancer immunotherapy. Cancer Treat Rev. 2010;36:458–67.

    CAS  PubMed  CrossRef  Google Scholar 

  30. Skok K, Hladnik G, Grm A, Crnjac A. Malignant pleural effusion and its current management: a review. Medicina (Kaunas). 2019;55(8):490.

    CrossRef  Google Scholar 

  31. Porcel JM, Diaz JP, Chi DS. Clinical implications of pleural effusions in ovarian cancer. Respirology. 2012;17:1060–7.

    PubMed  CrossRef  Google Scholar 

  32. Ataseven B, Chiva LM, Harter P, Gonzalez-Martin A, du Bois A. FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited. Gynecol Oncol. 2016;142:597–607.

    PubMed  CrossRef  Google Scholar 

  33. Desai NR, Lee HJ. Diagnosis and management of malignant pleural effusions: state of the art in 2017. J Thorac Dis. 2017;9:S1111–22.

    PubMed  PubMed Central  CrossRef  Google Scholar 

  34. Li P, Graver A, Hosseini S, Mulpuru S, Cake L, Kachuik L, Zhang T, Amjadi K. Clinical predictors of successful and earlier pleurodesis with a tunnelled pleural catheter in malignant pleural effusion: a cohort study. CMAJ Open. 2018;6:E235–40.

    PubMed  PubMed Central  CrossRef  Google Scholar 

  35. Sterman DH, DeCamp MM, Feller-Kopman DJ, Maskell NA, Wahidi MM, Lee YCG, Gould MK, Rahman NM, Lewis SZ, Henry T, et al. Management of malignant pleural effusions. An official ATS/STS/STR clinical practice guideline. Am J Respir Crit Care Med. 2018;198:839–49.

    PubMed  CrossRef  Google Scholar 

  36. Bibby AC, Dorn P, Psallidas I, Porcel JM, Janssen J, Froudarakis M, Subotic D, Astoul P, Licht P, Schmid R, et al. ERS/EACTS statement on the management of malignant pleural effusions. Eur J Cardiothorac Surg. 2019;55:116–32.

    PubMed  CrossRef  Google Scholar 

  37. Cohen A, Lim CS, Davies AH. Venous thromboembolism in gynecological malignancy. Int J Gynecol Cancer. 2017;27:1970–8.

    PubMed  CrossRef  Google Scholar 

  38. Satoh T, Matsumoto K, Tanaka YO, et al. Incidence of venous thromboembolism before treatment in cervical cancer and the impact of management on venous thromboembolism after commencement of treatment. Thromb Res. 2013;131:e127Ye132.

    CrossRef  CAS  Google Scholar 

  39. Piccioli A, Falanga A, Baccaglini U, et al. Cancer and venous thromboembolism. Semin Thromb Hemost. 2006;32:694Y699.

    Google Scholar 

  40. Barbera L, Thomas G. Venous thromboembolism in cervical cancer. Lancet Oncol. 2008;9:54Y60.

    CrossRef  Google Scholar 

  41. Khorana AA, Dalal M, Lin J, et al. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Cancer. 2013;119:648Y655.

    CrossRef  CAS  Google Scholar 

  42. Barber EL, Clarke-Pearson DL. Prevention of venous thromboembolism in gynecologic oncology surgery. Gynecol Oncol. 2017;144:420–7.

    PubMed  CrossRef  Google Scholar 

  43. Selby LV, Sovel M, Sjoberg DD, McSweeney M, Douglas D, Jones DR, et al. Pre-operative chemoprophylaxis is safe major oncology operations and effective at preventing venous thromboembolism. J Am Coll Surg. 2016;222:129–37.

    PubMed  CrossRef  Google Scholar 

  44. Raskob GE, Hirsh J. Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery. Chest. 2003;124:379–85.

    CrossRef  Google Scholar 

  45. van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage. 2016;51(6):1070–1090.e9.

    PubMed  CrossRef  Google Scholar 

  46. Syrjala KL, Jensen MP, Mendoza ME, Yi JC, Fisher HM, Keefe FJ. Psychological and behavioral approaches to cancer pain management. J Clin Oncol. 2014;32(16):1703–11. https://doi.org/10.1200/JCO.2013.54.4825.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  47. Manolitas TP, Abdessalam S, Fowler JM. Chylous ascites following treatment for gynecologic malignancies. Gynecol Oncol. 2002;86:370–3.

    CrossRef  Google Scholar 

  48. Al-Busafi SA, Ghali P, Deschênes M, Wong P. Chylous ascites: evaluation and management. International Scholarly Research Notices. 2014; Article ID 240473. https://doi.org/10.1155/2014/240473

  49. Baiocchi G, Faloppa CC, Araujo RLC, et al. Chylous ascites in gynecologic malignancies: cases report and literature review. Arch Gynecol Obstet. 2010;281:677–81.

    PubMed  CrossRef  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anastasios Tranoulis .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Verify currency and authenticity via CrossMark

Cite this chapter

Tranoulis, A., Joy, H., Gupta, B. (2022). Management of Complications: Chemotherapy Related Complications, Acute Bowel Obstruction, Symptomatic Ascites and Pleural Effusion, Pulmonary Embolism, Deep Vein Thrombosis, Severe Pain, Chylous Ascites. In: Singh, K., Gupta, B. (eds) Gynecological Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-94110-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-94110-9_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-94109-3

  • Online ISBN: 978-3-030-94110-9

  • eBook Packages: MedicineMedicine (R0)